Literature DB >> 23857440

Comparison of three high flow oxygen therapy delivery devices: a clinical physiological cross-over study.

G Chanques1, F Riboulet, N Molinari, J Carr, B Jung, A Prades, F Galia, E Futier, J M Constantin, S Jaber.   

Abstract

AIM: High-flow-oxygen-therapy is provided by various techniques and patient interfaces, resulting in various inspired-fraction of oxygen (FiO2) and airway-pressure levels. However, tracheal measurements have never been performed.
METHODS: Three oxygen-delivery-devices were evaluated: 1) standard-high-flow-oxygen-facemask with reservoir-bag, 2) Optiflow(TM)-high-flow-nasal-cannulae and 3) Boussignac(TM)-oxygen-therapy-system. Main judgment criteria were airway-pressure and FiO2 measured in the trachea. The three devices were randomly evaluated in cross-over in 10 Intensive-Care-Unit patients using three oxygen flow-rates (15, 30 and 45 L/min) and two airway-tightness conditions (open and closed mouth). Airway-pressures and FiO2 were measured by a tracheal-catheter inserted through the hole of a tracheotomy tube. Comfort was evaluated by self-reporting. Data are presented as median [25-75th].
RESULTS: 1) Regarding oxygen-delivery devices, BoussignacTM provided the highest mean tracheal pressure (13.9 [10.4-14.5] cmH20) compared to Optiflow(TM) (2 [1-2.3] cmH2O, P<0.001). BoussignacTM provided both positive inspiratory and expiratory airway-pressures, whereas Optiflow(TM) provided only positive expiratory airway-pressure. Reservoir-bag-facemask provided airway pressure close to zero. For FiO2, highest value was obtained for both Optiflow(TM) and facemask (90%) compared to Boussignac(TM) (80%), P<0.01. 2) Regarding oxygen-flow, airway-pressure and FiO2 systematically increased with oxygen-flow with the three devices except airway-pressure for the facemask. 3) Regarding the open-mouth position, mean airway-pressure decreased with Optiflow(TM) only (2 [1.2-3.3] vs. 0.6 [0.3-1] cmH2O, P<0.001). Opening the mouth had little impact on FiO2. 4) finally, discomfort-intensities were low for both Optiflow(TM) and reservoir-bag-facemask compared to Boussignac(TM), P<0.01.
CONCLUSION: On one hand, Boussignac(TM) is the only device that generates a relevant positive-airway-pressure during both inspiration-and-expiration, independently of mouth-position. Optiflow(TM) provides a low positive-airway-pressure (<4 cmH2O), highly dependent of mouth-closing. The reservoir-bag-facemask provides no positive-airway-pressure. On the other hand, FiO2 are slightly but significantly higher for Optiflow(TM) and reservoir-bag-facemask than for Boussignac(TM). Discomfort was lesser for Optiflow(TM) and reservoir-bag-facemask.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23857440

Source DB:  PubMed          Journal:  Minerva Anestesiol        ISSN: 0375-9393            Impact factor:   3.051


  43 in total

1.  High-flow nasal cannula following extubation: is more oxygen flow useful after surgery?

Authors:  Emmanuel Futier; Samir Jaber
Journal:  Intensive Care Med       Date:  2015-06-13       Impact factor: 17.440

2.  Nasal high-flow preoxygenation for endotracheal intubation in the critically ill patient? Maybe.

Authors:  Gérald Chanques; Samir Jaber
Journal:  Intensive Care Med       Date:  2019-03-19       Impact factor: 17.440

3.  Effect of early postextubation high-flow nasal cannula vs conventional oxygen therapy on hypoxaemia in patients after major abdominal surgery: a French multicentre randomised controlled trial (OPERA).

Authors:  Emmanuel Futier; Catherine Paugam-Burtz; Thomas Godet; Linda Khoy-Ear; Sacha Rozencwajg; Jean-Marc Delay; Daniel Verzilli; Jeremie Dupuis; Gerald Chanques; Jean-Etienne Bazin; Jean-Michel Constantin; Bruno Pereira; Samir Jaber
Journal:  Intensive Care Med       Date:  2016-10-22       Impact factor: 17.440

4.  High-flow nasal cannula in postextubation management.

Authors:  Lu Chen; Hong-Liang Li; Laurent Brochard
Journal:  J Thorac Dis       Date:  2016-09       Impact factor: 2.895

5.  Apnoeic oxygenation via high-flow nasal cannula oxygen combined with non-invasive ventilation preoxygenation for intubation in hypoxaemic patients in the intensive care unit: the single-centre, blinded, randomised controlled OPTINIV trial.

Authors:  Samir Jaber; Marion Monnin; Mehdi Girard; Matthieu Conseil; Moussa Cisse; Julie Carr; Martin Mahul; Jean Marc Delay; Fouad Belafia; Gérald Chanques; Nicolas Molinari; Audrey De Jong
Journal:  Intensive Care Med       Date:  2016-10-11       Impact factor: 17.440

Review 6.  High-flow nasal oxygen therapy and noninvasive ventilation in the management of acute hypoxemic respiratory failure.

Authors:  Jean-Pierre Frat; Rémi Coudroy; Nicolas Marjanovic; Arnaud W Thille
Journal:  Ann Transl Med       Date:  2017-07

Review 7.  Use of high-flow nasal cannula oxygenation in ICU adults: a narrative review.

Authors:  Laurent Papazian; Amanda Corley; Dean Hess; John F Fraser; Jean-Pierre Frat; Christophe Guitton; Samir Jaber; Salvatore M Maggiore; Stefano Nava; Jordi Rello; Jean-Damien Ricard; François Stephan; Rocco Trisolini; Elie Azoulay
Journal:  Intensive Care Med       Date:  2016-03-11       Impact factor: 17.440

Review 8.  High-flow nasal cannulae for respiratory support in adult intensive care patients.

Authors:  Amanda Corley; Claire M Rickard; Leanne M Aitken; Amy Johnston; Adrian Barnett; John F Fraser; Sharon R Lewis; Andrew F Smith
Journal:  Cochrane Database Syst Rev       Date:  2017-05-30

Review 9.  Applications of Nasal High-Flow Oxygen Therapy in Critically ill Adult Patients.

Authors:  Jahan Porhomayon; Ali A El-Solh; Leili Pourafkari; Philippe Jaoude; Nader D Nader
Journal:  Lung       Date:  2016-05-03       Impact factor: 2.584

Review 10.  Non-invasive ventilation in cardiogenic pulmonary edema.

Authors:  Giuseppe Bello; Paolo De Santis; Massimo Antonelli
Journal:  Ann Transl Med       Date:  2018-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.